Kim Hyun-Jin, Kim Hack-Lyoung, Kim Myung-A
Division of Cardiology, Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.
Cardiovascular Center, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea.
Int J Heart Fail. 2025 Jul 22;7(3):162-172. doi: 10.36628/ijhf.2025.0024. eCollection 2025 Jul.
Heart failure (HF) in younger patients, who are typically active, can significantly affect their quality of life. We assessed the clinical features and prognosis of younger patients with acute HF according to changes in their left ventricular function.
This multi-center cohort study was conducted from March 2011 to February 2014 across 10 representative university hospitals. Adult aged <50 years at the time of admission for acute HF were included. Patients were classified into 2 groups according to changes in echocardiographic left ventricular ejection fraction (LVEF) at 1-year follow-up (improved LVEF group vs. non-improved LVEF group). The primary outcome was the incidence of all-cause mortality during the follow-up period.
Among the 437 patients, 14.6% experienced worsening LVEF at the 1-year follow-up. Fifty-six (12.8%) patients died during the follow-up. The non-improved LVEF group had a higher incidence of all-cause mortality than the improved LVEF groups (32.8% vs. 9.4%, p0.001). Clinical outcomes, including all-cause death, cardiac death, and HF readmission were significantly worse in the non-improved LVEF group. Multivariate logistic regression analysis identified angiotensin converting enzyme inhibitor use at discharge as an independent predictor of reduced risk of non-improved LVEF (odds ratio, 0.37; 95% confidence interval, 0.171-0.786).
Worsening LVEF was associated with poor clinical prognosis in younger patients hospitalized for acute HF. Clinicians should be aware of the characteristics of younger patients with acute HF and monitoring and treating changes in LVEF in younger patients with acute HF is crucial for improving clinical outcomes.
年轻患者通常较为活跃,心力衰竭(HF)会显著影响其生活质量。我们根据左心室功能变化评估了年轻急性HF患者的临床特征及预后。
本多中心队列研究于2011年3月至2014年2月在10家代表性大学医院开展。纳入急性HF入院时年龄<50岁的成年人。根据1年随访时超声心动图左心室射血分数(LVEF)的变化将患者分为两组(LVEF改善组与LVEF未改善组)。主要结局为随访期内全因死亡率。
437例患者中,14.6%在1年随访时LVEF恶化。56例(12.8%)患者在随访期间死亡。LVEF未改善组全因死亡率高于LVEF改善组(32.8%对9.4%,p<0.001)。LVEF未改善组的临床结局,包括全因死亡、心源性死亡和HF再入院情况均显著更差。多因素逻辑回归分析确定出院时使用血管紧张素转换酶抑制剂是LVEF未改善风险降低的独立预测因素(比值比,0.37;95%置信区间,0.171 - 0.786)。
LVEF恶化与因急性HF住院的年轻患者不良临床预后相关。临床医生应了解年轻急性HF患者的特征,监测和治疗年轻急性HF患者的LVEF变化对改善临床结局至关重要。